Abstract:Midbrain dopaminergic neurons play an important role in the etiology of neurodevelopmental and neurodegenerative diseases. They also represent a potential source of transplanted cells for therapeutic applications. In vitro differentiation of functional midbrain dopaminergic neurons provides an accessible platform to study midbrain neuronal dysfunction and can be used to examine obstacles to dopaminergic neuronal development. Emerging evidence and impressive advances in human induced pluripotent stem cells, with tuned neural induction and differentiation protocols, makes the production of induced pluripotent stem cell-derived dopaminergic neurons feasible. Using SB431542 and dorsomorphin dual inhibitor in an induced pluripotent stem cell-derived neural induction protocol, we obtained multiple subtypes of neurons, including 20% tyrosine hydroxylase-positive dopaminergic neurons. To obtain more dopaminergic neurons, we next added sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8) on day 8 of induction. This increased the proportion of dopaminergic neurons, up to 75% tyrosine hydroxylase-positive neurons, with 15% tyrosine hydroxylase and forkhead box protein A2 (FOXA2) co-expressing neurons. We further optimized the induction protocol by applying the small molecule inhibitor, CHIR99021 (CHIR).This helped facilitate the generation of midbrain dopaminergic neurons, and we obtained 31-74% midbrain dopaminergic neurons based on tyrosine hydroxylase and FOXA2 staining. Thus, we have established three induction protocols for dopaminergic neurons. Based on tyrosine hydroxylase and FOXA2 immunostaining analysis, the CHIR, SHH, and FGF8 combined protocol produces a much higher proportion of midbrain dopaminergic neurons, which could be an ideal resource for tackling midbrain-related diseases.

Human midbrain dopaminergic progenitors

Requirements for human haematopoietic stem/progenitor cells

Requirements for human cardiomyocytes

Requirements for human‐induced pluripotent stem cells

Single-cell Transcriptomics Reveals the Cell Fate Transitions of Human Dopaminergic Progenitors Derived from Hescs.

Specification of Midbrain Dopamine Neurons from Primate Pluripotent Stem Cells

Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells

Requirements for human embryonic stem cells

BrainSTEM: A multi-resolution fetal brain atlas to assess the fidelity of human midbrain cultures

Directed differentiation of dopamine neurons from human pluripotent stem cells.

Multiple Factors to Assist Human-Derived Induced Pluripotent Stem Cells to Efficiently Differentiate into Midbrain Dopaminergic Neurons.

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use

Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01

Dopaminergic Neuron-Related Stem Cells

Requirments for primary human hepatocyte

General requirements for the production of extracellular vesicles derived from human stem cells

Standards of clinical-grade mesenchymal stromal cell preparation and quality control (2020 China Version)

A High-content Screen Identifies Compounds Promoting the Neuronal Differentiation and the Midbrain Dopamine Neuron Specification of Human Neural Progenitor Cells

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons